Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934

For the transition period from _______ to _______

Commission file number: 001-32501

REED’S, INC.

(Exact name of registrant as specified in its charter)

Delaware		35-2177773
(State of incorporation)		(I.R.S. Employer Identification No.)

201 Merritt 7, Norwalk, CT. 06851

(Address of principal executive offices) (Zip Code)

(800) 997-3337

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: None

Title of Each Class		Trading Symbol		Names of each exchange on which registered

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: There were a total of 4,187,291 shares of Common Stock outstanding as of May 10, 2024.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

Large Accelerated Filer ☐	Accelerated Filer ☐	Non-Accelerated Filer ☒
Smaller Reporting Company ☒	Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the issuer is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

There are 4,187,291 shares outstanding as of May 10^th, 2024.

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION		F-1

Item 1. Condensed Financial Statements		F-1

Condensed Balance Sheets - March 31, 2024 (Unaudited) and December 31, 2023		F-1

Condensed Statements of Operations for the three months ended March 31, 2024 and 2023 (Unaudited)		F-2

Condensed Statements of Changes in Stockholders’ Deficit for the three months ended March 31, 2024 and 2023 (Unaudited)		F-3

Condensed Statements of Cash Flows for the three months ended March 31, 2024 and 2023 (Unaudited)		F-4

Notes to Condensed Financial Statements three months ended March 31, 2024 and 2023 (Unaudited)		F-5

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		1

Item 3. Quantitative and Qualitative Disclosures About Market Risk		6

Item 4. Controls and Procedures		6

PART II – OTHER INFORMATION		7

Item 1. Legal Proceedings		7

Item 1A. Risk Factors		7

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		7

Item 3. Defaults Upon Senior Securities		7

Item 4. Mine Safety Disclosures		7

Item 5. Other Information		7

Item 6. Exhibits		7

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS AND INFORMATION

This report contains statements reflecting our views about our future performance that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (Reform Act). Statements that constitute forward-looking statements within the meaning of the Reform Act are generally identified through the inclusion of words such as “aim,” “anticipate,” “believe,” “drive,” “estimate,” “expect,” “expressed confidence,” “forecast,” “future,” “goal,” “guidance,” “intend,” “may,” “objective,” “outlook,” “plan,” “position,” “potential,” “project,” “seek,” “should,” “strategy,” “target,” “will” or similar statements or variations of such words and other similar expressions. All statements addressing our future operating performance, and statements addressing events and developments that we expect or anticipate will occur in the future, are forward-looking statements within the meaning of the Reform Act. These forward-looking statements are based on currently available information, operating plans and projections about future events and trends. They inherently involve risks and uncertainties that could cause actual results to differ materially from those predicted in any such forward-looking statement. These risks and uncertainties include, but are not limited to, those described in “Part I, Item 1A. Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (“2023 Form 10-K”) as updated by “Part II, Item 1A” of this report should be considered when evaluating our trends and future results. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. The discussion of risks in this report is by no means all-inclusive but is designed to highlight what we believe are important factors to consider when evaluating our future performance.

Part I – FINANCIAL INFORMATION

Item 1. Financial Statements

REED’S, INC,

CONDENSED BALANCE SHEETS

(Amounts in thousands, except share amounts)

	March 31, 2024			December 31, 2023
	(Unaudited)
ASSETS
Current assets:
Cash	$	314		$	603
Accounts receivable, net of allowance of $258 and $860, respectively		3,251			3,571
Inventory		12,017			11,300
Receivable from former related party		264			259
Prepaid expenses and other current assets		2,332			2,028
Total current assets		18,178			17,761

Property and equipment, net of accumulated depreciation of $1,136 and $1,068, respectively		441			493
Intangible assets		631			629
Total assets	$	19,250		$	18,883

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	8,484		$	9,133
Accrued expenses		872			1,096
Revolving line of credit, net of capitalized financing costs of $161 and $201, respectively		7,844			9,758
Payable to former related party		331			259
Current portion of convertible notes payable, net of debt discount of $509 and $424, respectively		7,339			6,737
Current portion of lease liabilities		155			207
Total current liabilities		25,025			27,190

SAFE agreements		4,097			-
Convertible note payable, net of debt discount of $45 and $148, respectively, less current portion		10,853			10,874
Total liabilities		39,975			38,064

Stockholders’ deficit:
Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 9,411 shares issued and outstanding		94			94
Common stock, $.0001 par value, 180,000,000 shares authorized; 4,187,291 and 4,187,291 shares issued and outstanding, respectively		-			-
Additional paid in capital		119,581			119,452
Accumulated deficit		(140,400	)		(138,727	)
Total stockholders’ deficit		(20,725	)		(19,181	)
Total liabilities and stockholders’ deficit	$	19,250		$	18,883

The accompanying notes are an integral part of these financial statements.

F-1

REED’S, INC.

CONDENSED STATEMENTS OF OPERATIONS

For the Three Months Ended March 31, 2024 and 2023

(Unaudited)

(Amounts in thousands, except share and per share amounts)

	March 31, 2024			March 31, 2023
Net Sales	$	9,595		$	11,157
Cost of goods sold		6,182			8,459
Gross profit		3,413			2,698

Operating expenses:
Delivery and handling expense		1,502			2,120
Selling and marketing expense		1,093			1,447
General and administrative expense		1,468			1,709
Total operating expenses		4,063			5,276

Loss from operations		(650	)		(2,578	)

Interest expense		(1,023	)		(1,779	)

Net loss	$	(1,673	)	$	(4,357	)

Net loss per share – basic and diluted	$	(0.40	)	$	(1.70	)

Weighted average number of shares outstanding – basic and diluted		4,187,291			2,559,855

The accompanying notes are an integral part of these condensed financial statements.

F-2

REED’S, INC.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

For the Three Months Ended March 31, 2024 and 2023

(Unaudited)

(Amounts in thousands except share amounts)

	Shares		Amount		Shares		Amount		Capital		Deficit			Deficit
	Common Stock				Preferred Stock				Additional Paid In		Accumulated			Total Stockholders’
	Shares		Amount		Shares		Amount		Capital		Deficit			Deficit
Balance, December 31, 2023		4,187,291	$	-		9,411	$	94	$	119,452	$	(138,727	)	$	(19,181	)
Fair value of vested options		-		-		-		-		129		-			129
		-		-		-		-		-		-			-
Net loss		-		-		-		-		-		(1,673	)		(1,673	)
Balance, March 31, 2024		4,187,291	$	-		9,411	$	94	$	119,581	$	(140,400	)	$	(20,725	)

	Common Stock					Preferred Stock				Additional Paid In			Accumulated			Total Stockholders’
	Shares			Amount		Shares		Amount		Capital			Deficit			Equity
Balance, December 31, 2022		2,519,485		$	-		9,411	$	94	$	114,635		$	(123,199	)	$	(8,470	)
Balance		2,519,485		$	-		9,411	$	94	$	114,635		$	(123,199	)	$	(8,470	)

Fair value of vested options		-					-				229						229
Fair value of vested restricted shares granted to officers		750					-				4						4
Repurchase of common stock		(274	)				-				(1	)					(1	)
Common shares issued for financing costs		82,438					-				273						273
Net loss		-			-		-		-		-			(4,357	)		(4,357	)
Balance, March 31, 2023		2,602,399		$	-		9,411	$	94	$	115,140		$	(127,556	)	$	(12,322	)
Balance		2,602,399		$	-		9,411	$	94	$	115,140		$	(127,556	)	$	(12,322	)

The accompanying notes are an integral part of these condensed financial statements.

F-3

REED’S, INC.

CONDENSED STATEMENTS OF CASH FLOWS

For the Three Months Ended March 31, 2024 and 2023

(Unaudited)

(Amounts in thousands)

	March 31, 2024			March 31, 2023
Cash flows from operating activities:
Net loss	$	(1,673	)	$	(4,357	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation		29			47
Amortization of debt discount		144			281
Fair value of vested options		129			229
Fair value of vested restricted shares granted to officers		-			4
Change in allowance for doubtful accounts		(601	)		(39	)
Inventory write-downs		(783	)		(228	)
Accrued interest		564			1,113
Changes in operating assets and liabilities:
Accounts receivable		922			1,044
Inventory		66			1,102
Prepaid expenses and other assets		(1,305	)		338
Decrease in right of use assets		39			32
Accounts payable		351			1,360
Accrued expenses		(225	)		235
Lease liabilities		(52	)		(44	)
Net cash provided by (used in) operating activities		(2,395	)		1,117
Cash flows from investing activities:
Trademark costs		(2	)		-
Purchase of property and equipment		(16	)		-
Net cash used in investing activities		(18	)		-
Cash flows from financing activities:
Proceeds from line of credit		8,285			8,699
Payments on line of credit		(10,239	)		(12,120	)
Proceeds from convertible note payable, net of expenses		-			2,405
Proceeds from SAFE agreement		4,097			-
Payment of cost recorded as debt discount		(86	)
Repurchase of common stock		-			(1	)
Amounts from former related party, net		67			(166	)
Net cash provided by (used in) financing activities		2,124			(1,183	)

Net increase (decrease) in cash		(289	)		(66	)
Cash at beginning of period		603			533
Cash at end of period	$	314		$	467

Supplemental disclosures of cash flow information:
Cash paid for interest	$	318		$	390
Non-cash investing and financing activities:
Reclass of prepaid expenses and accounts payable	$	1,000		$	0

The accompanying notes are an integral part of these condensed financial statements.

F-4

REED’S, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

Three Months Ended March 31, 2024 and 2023 (Unaudited)

(In thousands, except share and per share amounts)

1. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed financial statements of Reed’s, Inc. (the “Company”, “we”, “us”, or “our”), have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 1, 2024. The accompanying condensed financial statements are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company’s financial position as of March 31, 2024, and the results of its operations and its cash flows for the three months ended March 31, 2024 and 2023. The balance sheet as of December 31, 2023 is derived from the Company’s audited financial statements.

The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2024.

Liquidity

For the three months ended March 31, 2024, the Company recorded a net loss of $1,673 and used cash in operations of $2,395. In accordance with Accounting Standards Codification (“ASC”) 205-40, Going Concern, the Company’s management has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying financial statements were issued. As of the issuance date of these financial statements, management expects that the Company’s existing cash of $314, which includes $4,100 of additional cash received during the three months ended March 31, 2024, from investments with significant stockholders plus expected cash from operations, will be sufficient to fund the Company’s current operating plan for at least twelve months from the date of issuance of these financial statements. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners, strategic transactions or through obtaining credit from financial institutions. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.

We have also taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.

Recent Trends - Market Conditions

Although the U.S. economy continued to grow throughout 2023 and into Q1 2024, the higher inflation, the actions by the Federal Reserve to address inflation, and rising energy prices create uncertainty about the future economic environment which will continue to evolve and may impact our business in future periods. We have experienced supply chain challenges, including increased lead times, as well as inflation of raw materials, logistics and labor costs due to availability constraints and high demand. Although we regularly monitor companies in our supply chain, and use alternative suppliers when necessary and available, supply chain constraints could cause a disruption in our ability to obtain raw materials required to manufacture our products and adversely affect our operations.

During the three months ended March 31, 2024, the Company experienced moderation from the elevated freight costs experienced in 2023. The average cost of shipping and handling for the three months ended March 31, 2024, was $3.01 per case, as compared to $3.46 per case for the three months ended March 31, 2023. Although the Company has experienced decreases in freight costs over the last four quarters, in the Company’s opinion there remains a volatile environment and the Company will continue to monitor pricing and availability in transportation. Mitigation plans have been implemented to manage this risk. The Company has been negatively impacted by supply chain challenges affecting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins. The Company has experienced moderation in inflation and anticipates this to continue throughout 2024.

F-5

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for credit loss reserves for accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in the determination of the Company’s liquidity.

Revenue Recognition

The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers (“ASC 606”). Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfilment activity rather than a promised service to the customer. All of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them.

The Company does not allow for returns, except for damaged products when the damage occurred pre-fulfilment. Damaged product returns have historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.

Loss per Common Share

Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings (loss) per share is computed by dividing the net income applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive.

For the periods ended March 31, 2024 and 2023, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:

	March 31, 2024		March 31, 2023
Warrants		549,292		235,946
Options		141,869		174,460
Convertible note payable		1,557,066		1,257,491
Unvested restricted common stock		-		710
Common stock equivalent of Series A Convertible Preferred stock		753		753
Total		2,248,980		1,669,360

Stock Compensation Expense

The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.

F-6

The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

Advertising Costs

Advertising costs are expensed as incurred and are included in selling and marketing expense. Advertising costs aggregated $17 and $55 for the three months ended March 31, 2024 and 2023, respectively.

Concentrations

Net sales. During the three months ended March 31, 2024, the Company’s two largest customers accounted for 17% and 16% of net sales, respectively. During the three months ended March 31, 2023, the Company’s two largest customers accounted for 18% and 12% of net sales, respectively. No other customers exceeded 10% of net sales in either period.

Accounts receivable. As of March 31, 2024, the Company had accounts receivable from one customer which comprised 29% of its gross accounts receivable. As of December 31, 2023, the Company had accounts receivable from three customers which comprised 24%, 15% and 11% of its gross accounts receivable, respectively. No other customers exceeded 10% of gross accounts receivable in either period.

The Company utilizes co-packers to produce 100% of its products. During the three months ended March 31, 2024 and the year ended December 31, 2023, the Company utilized six separate co-packers for most its production and bottling of beverage products in the United States. The Company has long-standing relationships with two different co-packers, and a third co-packing agreement with California Custom Beverage LLC (“CCB”), a former related party (see Note 11). Although there are other packers, a change in co-packers may cause a delay in the production process, which could ultimately affect operating results.

Purchases from vendors. During the three months ended March 31, 2024, the Company’s largest vendor accounted for approximately 10% of all purchases. During the three months ended March 31, 2023, the Company’s largest vendor accounted for approximately 11% of all purchases. No other vendors exceeded 10% of all purchases in either period.

Accounts payable. As of March 31, 2024, one vendor accounted for 11% of total accounts payable. As of December 31, 2023, two vendors accounted for 10% and 10% of total accounts payable, respectively. No other vendors exceeded 10% of accounts payable in either period.

Fair Value of Financial Instruments

The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. ASC 820 defines the following levels of subjectivity associated with the inputs:

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.

Level 3—Unobservable inputs based on the Company’s assumptions.

The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable, short-term bank loans, accounts payable, notes payable and other payables, approximate their fair values because of the short maturity of these instruments. The carrying values of capital lease obligations and long-term financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.

Reclassifications

Certain prior year amounts have been reclassified for consistency with the current period presentation. Collection from customers amounting to $1,217 that was previously presented as a deduction from prepaid expenses have been reclassed as an offset against accounts receivable. These reclassifications had no effect on the reported results of operations or cash flows.

Recent Accounting Pronouncements

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosure, which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expense categories that are regularly provided to the chief operating decision maker and included in each reported measure of a segment’s profit or loss. The update also requires all annual disclosures about a reportable segment’s profit or loss and assets to be provided in interim periods and for entities with a single reportable segment to provide all the disclosures required by ASC 280, Segment Reporting, including the significant segment expense disclosures. This standard will be effective for the Company on January 1, 2024 and interim periods beginning in fiscal year 2025, with early adoption permitted. The updates required by this standard should be applied retrospectively to all periods presented in the financial statements. The Company does not expect this standard to have a material impact on its results of operations, financial position or cash flows.

F-7

In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. The ASU requires buyers to disclose information about their supplier finance programs. Interim and annual requirements include the disclosure of outstanding amounts under the obligations as of the end of the reporting period, and annual requirements include a roll-forward of those obligations for the annual reporting period, as well as a description of payment and other key terms of the programs. This update is effective for annual periods beginning after December 15, 2022, and interim periods within those fiscal years, except for the requirement to disclose roll-forward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted ASU 2022-04 on January 1, 2023, and there was no material impact on our financial statements.

Other recent accounting pronouncements and guidance issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

2. Inventory

Inventory is valued at the lower of cost (first-in, first-out) or net realizable value, net of write downs, and is comprised of the following (in thousands):

Schedule of Inventory

	March 31, 2024		December 31, 2023
Raw materials and packaging	$	6,766	$	6,445
Finished products		5,251		4,855
Total	$	12,017	$	11,300

3. Property and Equipment

Property and equipment are comprised of the following (in thousands):

Schedule of Property and Equipment

	March 31, 2024			December 31, 2023
Right-of-use assets under operating leases	$	724		$	724
Computer hardware and software		400			400
Machinery and equipment		352			352
Construction in progress		101			85
Total cost		1,577			1,561
Accumulated depreciation and amortization		(1,136	)		(1,068	)
Net book value	$	441		$	493

F-8

Depreciation expense for the three months ended March 31, 2024 and 2023 was $29 and $47, respectively, and amortization of right-of-use assets for the three months ended March 31, 2024 and 2023 was $39 and $32, respectively.

4. Intangible Assets

Intangible assets consist of the following (in thousands):

Summary of Intangible Assets

	March 31, 2024		December 31, 2023
Brand names	$	576	$	576
Trademarks		55		53
Total	$	631	$	629

5. Line of Credit

The Company’s credit facility consisted of the following (in thousands):

	March 31, 2024			December 31, 2023
Line of credit – Alterna Capital Solutions	$	8,005		$	9,959
Less: capitalized financing costs		(161	)		(201	)
Total	$	7,844		$	9,758

In March, 2022, the Company entered into a financing agreement for a line of credit with Alterna Capital Solutions (“ACS”) The ACS line of credit is for a term of 3 years, provides for borrowings of up to $13,000, and is secured by eligible accounts receivable and inventory, and are subject to a collateral sharing agreement with Whitebox, another secured lender (see Note 6). An over advance rider provides for up to $400 of additional borrowing above the collateralized base (the “Over Advance”) up to a total borrowing of $13,000. As of March 31, 2024, there was no remaining availability under the line of credit, and $4,995 of borrowing capacity available.

Borrowings based on receivables bears an interest of prime plus 4.75% but not less than 8.0% (13.25% at March 31, 2024 and 13.25% at December 31, 2023). Borrowings based on inventory bears an interest of prime plus 5.25% but not less than 8.5% (13.90% at March 31, 2024 and 13.90% at December 31, 2023). The additional over advance rider bears a rate of prime plus 12.75%, but not less than 16.00% (18.00% at March 31, 2024 and 18.00% at December 31, 2023). Additionally, the line of credit is subject to monthly monitoring fee of $1 with a minimum usage requirement on the credit facility. A loan balance of less than $1,500 will bear interest at a rate in line with account receivables advances plus the monthly monitoring fee of $1.

The Company incurred $483 of direct costs of the transaction, consisting primarily of broker, bank and legal fees. These costs have been capitalized and are being amortized over the 3-year life of the ACS agreement. The unamortized debt discount balance was $201 at December 31, 2023. For the three months ended March 31, 2024, amortization of debt discount was $40, and as of March 31, 2024, the remaining unamortized debt discount balance is $161.

6. Secured Convertible Notes Payable

Amounts outstanding under the Company’s convertible notes payable are as follows (amounts in 000’s except share amounts):

	March 31, 2024			December 31, 2023
Secured Convertible “Original” Notes Payable (A)	$	10,250		$	10,250
Secured Convertible “Option”” Notes Payable (B)		4,050			4,050
Secured Convertible “Option”” Notes Payable		4,050			4,050
Accrued interest		1,457			1,059

Accrued interest on excess debt borrowing		2,989			2,824
Capitalized financing costs		(554	)		(572	)
Total	$	18,192		$	17,611

Secured Convertible Notes

(A)

In May 2022, the Company issued $11,250 of convertible notes payable (the “Original Notes”) to entities affiliated with Whitebox Advisors, LLC (collectively, “Whitebox”). The Original Notes bear interest at 10% per annum (with 5% per annum payable in cash and 5% per annum payable in kind (“PIK”) by adding such PIK interest to the principal amount of the notes), are secured by substantially all of the Company’s assets (including all of its intellectual property) and are subject to a collateral sharing agreement with Alterna Capital (ACS), the Company’s existing secured lender. The Original Notes mature the earlier of March 31, 2025 or the scheduled maturity of any unsecured indebtedness incurred by the Company that is junior in right of payment to Note obligations. The Original Notes together with the Option Notes are collectively referred to as the “Notes”. Upon conversion or early payment, holders of the Notes are entitled to receive an interest make-whole payment, as defined, equal to the sum of the remaining scheduled payments of interest on the Notes that would be due at maturity, payable, at the Company’s option, in cash or in shares of common stock. Effective August 11, 2022, the Notes were amended to add a 10% fee for the amount that the Company’s line of credit with ACS exceeds $6,000, as defined (the “Excess ABL Amount”). Effective June 30, 2023, the Excess ABL Amount was amended to $7,500. At March 31,2024 and December 31, 2023, the principal balance of the Original Notes was $10,250.

The Original Notes have an amortization feature which requires the Company to make monthly payments of principal of $200 plus accrued interest, payable in cash or in shares of the Company’s common stock at the option of the Company, based on 90% of the average prices of the Company’s common stock, as defined During 2023, Whitebox waived the requirement for the Company to pay the December 2022 to October 2023 monthly amortization payments on the Original Notes. The November 2023 amortization payment of $200 principal was paid, and the amortization payment for December 2023 to May 2024 was waived. The parties agreed that amortization period shall resume on June 1, 2024.

The terms of the Original Notes contained conversion terms that are expected to be amended, subject to satisfaction of certain conditions. Under the revised terms, the conversion price of the Original Notes will be between 125% and 145% of the effective price of the company’s subsequent equity offering, with the premium set based on the aggregate gross proceeds realized by the company in the offering and the conversion price subject to a cap of $7.50 per share.

In addition on February 12, 2024, subject to the satisfaction of certain conditions, the parties agreed that a portion of the outstanding ABL accrued fees will be satisfied through payment of $132 in cash and the issuance of shares of the Company’s common stock (up to the beneficial ownership limitation applicable to each holder) at a value per share equal to the lesser of $1.50 or the per share price of securities issued in the Company’s subsequent equity offering. The remaining balance of any outstanding accrued ABL fees will be added to the principal amount of the Notes. The $132 has not been paid nor any shares issued as of the date of these financial statements.

F-9

(B)

In February 2023 and May 2023, the Company issued an aggregate of $4,050 of additional Option Notes to Whitebox that substantially have the same terms as the Original Notes, except the Option Notes issued in 2023 do not require any amortization payments, initially were to bear interest at 10% payable in cash, and were initially due four months after issuance. On February 12, 2024, the parties agreed to change the terms so that the Option Notes shall bear interest at a rate of 10% per annum, with 5% per annum payable in cash and 5% per annum payable (“in kind” by adding such PIK interest to the unpaid principal amount. In addition, the parties agreed, subject to certain outstanding conditions, to amend the maturity date to the earlier of March 31, 2025 or the scheduled maturity of any unsecured indebtedness incurred by the Company that is junior in right of payment to Note obligations. Once they are amended, the Company shall have the right at any time prior to the date that is the 180th day from the effective date to prepay the amended and restated Option Notes, in whole or in part, at a price equal to 102% of the principal amount plus all accrued and unpaid interest thereon to the date of prepayment. At March 31, 2024 and December 31, 2023, the principal balance of the Option Notes was $4,050.

The terms of the Original Notes contained conversion terms that are expected to be amended , subject to the satisfaction of certain conditions by the Company. Under the revised terms, the conversion price of the Option Notes will be 120% of the arithmetic average of the Daily VWAP for the five (5) VWAP Trading Days beginning on, and including, the VWAP Trading Day immediately following the consummation of an equity offering undertaken for purposes of satisfying the terms and conditions of the Waiver and Amendment

Waiver of Default

On February 12, 2024, the Company entered into a Limited Waiver, Deferral, and Amendment and Restatement Agreement (the “Waiver and Amendment”) with each holder (each an entity affiliated with Whitebox Advisors, LLC) of the Original and Option Notes payable to Whitebox (the “Notes”). Subject to the Waiver and Amendment, the holders agreed to temporarily waive certain events of default under the Notes, including the failure to pay Excess ABL Amounts and the failure to pay amortization payments due December 1, 2023 to April 30, 2024. Subject to satisfaction of certain conditions by March 31, 2024, the parties further agreed to amend and restate the Notes, to extend the maturity date of the Option Notes originally due November 28, 2023, to March 31, 2025 and to equitize certain interest and fees owing on the Notes.

The conversion rate under the amended and restated notes is to be based on the pricing and size of the Company’s proposed equity financing of a minimum of $3 million (which will include conversion of approximately $4.1 million of previously funded SAFE investments into equity of the Company). Delays related to the Company’s evaluation of long term financing options have delayed the proposed financing. On April 1, 2024 the parties executed the Amended Limited Waiver, Deferral, and Amendment and Restatement Agreement (“Amended Waiver”). Subject to certain terms and conditions set forth in the Amended Waiver, the holders temporarily waived certain specified events of default under the Notes to April 30, 2024 and extended the waiver of monthly amortization payments to April 30, 2024. In addition, Reed’s remitted a partial interest payment of $100 to the holders.

Accrued Interest

At December 31, 2023, the balance of accrued interest was $3,883. During the period ended March 31, 2024, the Company recorded interest of $563, made up of $398 of interest on the convertible notes, and $165 related to the excess ABL fees. At March 31, 2024, the balance of accrued interest was $4,446.

Debt Discount

At December 31, 2023, the unamortized debt discount was $572. During the period ended March 31, 2024, the Company incurred $86 of costs for the aforementioned waivers. These costs have been capitalized and are being amortized over the term of the convertible notes or waiver period. For the three months ended March 31, 2024, amortization of debt discount was $104, and as of March 31, 2024, the remaining unamortized debt discount balance is $554.

F-10

7. Leases Liabilities

During the three months ended March 31, 2024 and 2023, lease costs totaled $39 and $32, respectively.

As of December 31, 2023, operating lease liabilities totaled $207. During the three months ended March 31, 2024, the Company made payments of $52 towards its operating lease liability. As of March 31, 2024, operating lease liabilities totaled $155.

As of March 31, 2024, the weighted average remaining lease terms for an operating lease are 0.75 years. As of March 31, 2024, the weighted average discount rate on the operating lease is 12.60%.

8. Simple Agreements for Future Equity (“SAFE”) Investments

During the first quarter of 2024, the Company received $4.1 million in gross proceeds from three significant stockholders of the Company, D&D Source of Life Holding LTD (“D&D”) and Union Square Park Partners LP, and John J. Bello, the Company’s Chairman, pursuant to Simple Agreements for Future Equity (“SAFE”) agreements. The SAFE investments will convert into the next equity financing of Reed’s on the same terms and conditions as investors in Reed’s next equity financing at the lesser of $1.50 per share or the per share price in the financing. Until such time as the SAFE investments convert to equity the approximately $4.1 million received is recorded as a liability. D&D was given the right to designate a second independent director nominee to the board of directors of Reed’s and the company agreed to limit the size of its board of directors to nine (9) for so long as D&D owns 25% or more of the equity securities of the Company.

9. Stock-Based Compensation

Stock Options

The following table summarizes stock option activity during the three months ended March 31, 2024:

Schedule of Stock Option Activity

	Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Terms (Years)		Aggregate Intrinsic Value
Outstanding at December 31, 2023		145,012		$	45.09		6.75	$	-
Granted		-		$	-
Exercised		-		$	-
Unvested forfeited		-		$	-
Vested forfeited		(3,143	)	$	45.05
Outstanding at March 31, 2024		141,869		$	44.03		6.50	$	-
Exercisable at March 31, 2024		111,583		$	51.09		6.07	$	-

During the three months ended March 31, 2024 and 2023, the Company recognized $129 and $229 of compensation expense relating to vested stock options. As of March 31, 2024, the aggregate amount of unvested compensation related to stock options was approximately $314 which will be recognized as an expense as the options vest in future periods through March 28, 2027.

As of March 31, 2024, the outstanding and exercisable options have no intrinsic value. The aggregate intrinsic value was calculated as the difference between the closing market price as of March 31, 2024, which was $1.63, and the exercise price of the outstanding stock options.

F-11

10. Stock Warrants

The Company’s warrant activity during the three months ended March 31, 2024 is as follows:

Schedule of Warrant Activity

	Shares		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Terms (Years)		Aggregate Intrinsic Value

Outstanding at December 31, 2023		549,292	$	8.77		2.84	$	-
Granted		-		-		-
Exercised		-		-		-
Forfeited		-		-		-
Outstanding at March 31, 2024		549,292	$	8.77		2.59	$	-
Exercisable at March 31, 2024		549,292	$	8.77		2.59	$	-

As of March 31, 2024, the outstanding and exercisable warrants have no aggregate intrinsic value. The aggregate intrinsic value was calculated as the difference between the closing market price as of March 31, 2024, which was $1.63, and the exercise price of the Company’s warrants to purchase common stock.

11. Transactions with California Custom Beverage, LLC, former related party

In December 2018, the Company signed a co-packing agreement with California Custom Beverage, LLC’s (“CCB”), an entity owned by Christopher J. Reed, a former related party, pursuant to which CCB agreed to produce certain products for the Company for agreed fees. The co-packing agreement, as amended, includes certain provisions for product inputs, shrinkage, and quality assurance. Also beginning in 2019, CCB agreed to pay the Company a 5% royalty through 2021 on certain private label sales made by CCB.

At March 31, 2024 and 2023, accounts receivable due from and accounts payable due to CCB were as follows:

Schedule of Related Parties

	March 31, 2024			December 31, 2023
Accounts receivable, net of provision of $1,123 and $1,123 at March 31, 2024 and December 31, 2023, respectively		264			259
Accounts payable		(331	)		(259	)
Net (payable) receivable		(67	)		-

In addition, on April 19, 2023, the Company received a letter from CCB demanding payment of various amounts, including the $452] and $452 outstanding at March 31, 2024 and December 31, 2023, respectively. The Company has determined that the probability of realizing any loss on the demand from CCB is remote and therefore has not recorded any additional accruals related to the demand.

12. Commitments and Contingencies

During 2023, the firm engaged an investment bank to explore financing options for the Company. We have a maximum obligation of $1.2M in fees so far in this engagement. These fees will be recognized on a success basis and will be paid out only if a transaction is finalized.

In 2018, CCB assumed the monthly payments on our lease obligation for a Los Angeles manufacturing plant for payments through September 2024, and our release from the obligation by the lessor, however, is dependent upon CCB’s deposit of $1,200 of security with the lessor. As of March 31, 2024, $800 has been deposited with the lessor and Chris J. Reed has placed approximately 7,260 shares of the Company’s common stock valued at $12 that remain in escrow with the lessor.

From time to time, we are a party to claims and legal proceedings arising in the ordinary course of business. Our management evaluates our exposure to these claims and proceedings individually and in the aggregate and provides for potential losses on such litigation if the amount of the loss is estimable and the loss is probable.

We believe that there are no material litigation matters at the current time. Although the result of such litigation matters and claims cannot be predicted with certainty, we believe that the final outcome of such claims and proceedings will not have a material adverse impact on our financial position, liquidity, or results of operations.

13. Subsequent Events

Secured Convertible Notes Payable

The Company has not yet satisfied conditions required for issuance of the amended and restated Notes and equitization of certain interest and fees owing on the Notes. The conversion rate under the amended and restated Notes is to be based on the pricing and size of the Company’s proposed equity financing of a minimum of $3 million (which will include conversion of approximately $4.1 million of previously funded SAFE investments into equity of the Company). Delays related to the Company’s evaluation of long term financing options have delayed the proposed financing. On May 17, 2024, Reed’s entered into a Limited Waiver, Deferral, and Amendment and Restatement Agreement (the “Waiver and Amendment”) with each holder. The holders agreed to temporarily waive certain specified events of default and the payment of Excess ABL Fees through June 10, 2024. Further, the holders agreed to waive the payment of monthly amortization payments through June 30, 2024. Amortization payments are scheduled to resume on July 1, 2024. The Company further remitted $40 representing all interest (including default interest) to the holders and reimbursed the holders for certain fees and expenses.

F-12

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Our discussion and analysis is intended to help the reader understand our results of operations and financial condition and is provided as an addition to, and should be read in connection with, our condensed financial statements and the accompanying notes. Cautionary statements on page [ii] of this report and in “Part I, Item 1A. Risk Factors” of our 2023 Form 10-K as updated by “Part II, Item 1A” of this report, should be considered when evaluating our trends and future results.

In addition to our GAAP results, the following discussion includes Modified EBITDA as a supplemental measure of our performance. We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts, and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus interest expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, and one-time restructuring-related costs including employee severance and asset impairment.

The following discussion also includes the use of gross billing, a key performance indicator and metric. Gross billing represents invoiced amounts to distributors and retailers, excluding sales adjustments. Gross billing may include deductions from MSRP or “list price”, where applicable, and excludes promotional costs of generating such sales. Management utilizes gross billing to monitor operating performance of products and salespersons, which performance can be masked by the effect of promotional or other allowances. Management believes that the presentation of gross billing provides a useful measure of Reed’s operating performance.

Amounts presented in the discussion below are in thousands, except share and per share amounts.

Results of Operations

Overview

During the three months ended March 31, 2024, the Company continued to strengthen its supply chain, implement gross margin enhancement initiatives, drive efficiencies in transportation and warehouse costs and reduce operating expenses. In addition, it continues to build its innovation pipeline with sustained growth in Reed’s Real Ginger Ale, Virgil’s Zero Sugar handcrafted sodas, Reed’s Classic and Stormy Mule, and Reed’s Hard Ginger Ale.

The Company remains focused on driving sales growth, improving gross margin, and reducing freight costs. The sales growth focus is on channel expansion, increase in store placements, new product introduction and improved sales execution. The margin enhancement initiative is driven by packaging savings, co-packer upgrades, and better leveraged purchasing and improved efficiency. Underpinning these initiatives is a focus on strategically reducing operating costs particularly delivery and handling expenses. In addition, the Company continues to augment its co-packer network to drive further efficiencies and build proper levels of inventory at the appropriate location to maximize delivery metrics.

Recent Trends – Market Conditions

During the three months ended March 31, 2024, the Company experienced moderation from the elevated freight costs experienced in 2023. The average cost of shipping and handling for period March 31, 2024, was $3.01 per case, as compared to $3.46 per case for the period ended March 31, 2023. Although the Company has experienced decreases in freight costs over the last four quarters, in the Company’s opinion there remains a volatile environment and the Company will continue to monitor pricing and availability in transportation. Mitigation plans have been implemented to manage this risk. The Company has been negatively impacted by supply chain challenges affecting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins. The Company has experienced moderation in inflation and anticipates this to continue throughout 2024.

During the three months ended March 31, 2024, we continued to generate cash flows to meet our short-term liquidity needs, and we expected to maintain access to the capital markets.

Results of Operations – Three Months Ended March 31, 2024, as compared to March 31, 2023

The following table sets forth key statistics for the three months ended March 31, 2024 and 2023, respectively, in thousands.

	Three Months Ended March 31,						Pct.
	2024			2023			Change
Gross billing (A)	$	10,379		$	12,453			-17	%
Less: Promotional and other allowances (B)		784			1,296			-40	%
Net sales	$	9,595		$	11,157			-14	%

Cost of goods sold		6,182			8,459			-27	%
% of Gross billing		59	%		68	%
% of Net sales		64	%		76	%
Gross profit	$	3,413		$	2,698			28	%
% of Net sales		36	%		24	%

Expenses
Delivery and handling	$	1,502		$	2,120			-29	%
% of Net sales		16	%		19	%
Dollar per case ($)	$	3.01		$	3.46
Selling and marketing		1,093			1,447			-24	%
% of Net sales		11	%		13	%
General and administrative		1,468			1,709			-14	%
% of Net sales		15	%		15	%
Total operating expenses		4,063			5,276			-23	%

Loss from operations	$	(650	)	$	(2,578	)		-76	%

Interest expense and other expense	$	(1,023	)	$	(1,779	)		-42	%

Net loss	$	(1,673	)	$	(4,357	)		-62	%

Loss per share – basic and diluted	$	(0.40	)	$	(1.70	)		-77	%

Weighted average shares outstanding - basic & diluted		4,187,291			2,559,855			64	%

(A) We define gross billing as the total sales for the Company unadjusted for costs related to generating those sales. Management utilizes gross billing as an indicator of and to monitor operating performance of products and salespersons before the effect of any promotional or other allowances, which are determined in accordance with GAAP, and can mask certain performance issues. We believe that the presentation of gross billing provides a useful measure of our operating performance. Additionally, gross billing may not be comparable to similarly titled measures used by other companies, as gross billing has been defined by our internal reporting practices.

(B) We define promotional and other allowances as costs deducted from gross billing which are associated with generating those sales. Management utilizes promotional and other allowances as an indicator of and to monitor operating performance of products, salespersons, and customer agreements. We believe that the presentation of promotional and other allowances provides a useful measure of our operating performance. The presentation of promotional and other allowances facilitates an evaluation of their impact on the determination of net sales and the spending levels incurred or correlated with such sales. The expenditures described in this line item are determined in accordance with GAAP and meet GAAP requirements, the disclosure thereof does not conform to GAAP presentation requirements. Additionally, our definition of promotional and other allowances may not be comparable to similar items presented by other companies. Promotional and other allowances primarily include consideration given to the Company’s distributors or retail customers including, but not limited to the following: (i) reimbursements given to the Company’s distributors for agreed portions of their promotional spend with retailers, including slotting, shelf space allowances and other fees for both new and existing products; (ii) the Company’s agreed share of fees given to distributors and/or directly to retailers for in-store marketing and promotional activities; (iii) the Company’s agreed share of slotting, shelf space allowances and other fees given directly to retailers; (iv) incentives given to the Company’s distributors and/or retailers for achieving or exceeding certain predetermined sales goals; and (v) discounted or free products. Promotional and other allowances constitute a material portion of our marketing activities. The Company’s promotional allowance programs with its numerous distributors and/or retailers are executed through separate agreements in the ordinary course of business. These agreements generally provide for one or more of the arrangements described above and are of varying durations, ranging from one week to one year.

Sales, Cost of Sales, and Gross Margins

The following chart sets forth key statistics for the transition of the Company’s top line activity from the first quarter of 2023 through the first quarter of 2024.

		2024			2023			vs PY			Q1 Per Case
		Q1			Q1			Q1			2024			2023			vs PY
Cases:
	Reed’s		348			370			-6	%
	Virgil’s		151			241			-37	%
	Total Core		499			611			-18	%
	Non Core		-			2			-100	%
	Total		499			613			-19	%

Gross Billing:
	Core	$	10,377		$	12,333			-16	%	$	20.80		$	20.18			3	%
	Non Core		2			120			-98	%		-		$	60.60-
	Total	$	10,379		$	12,453			-17	%		20.80			20.31			2	%

Discounts:	Total	$	(784	)	$	(1,296	)		-40	%	$	(1.57	)	$	(2.11	)		-26	%

COGS:
	Core	$	(6,182	)	$	(8,422	)		-27	%	$	(12.39	)	$	(13.78	)		-10	%
	Non Core		-			(37	)		-100	%		-		$	(18.50	)
	Total	$	(6,182	)	$	(8,459	)		-27	%	$	(12.39	)	$	(13.80	)		-10	%

Gross Margin:		$	3,413		$	2,698			27	%	$	6.84		$	4.40			55	%
as % Net Sales			36	%		24	%

Sales, Cost of Sales, and Gross Margins

As part of the Company’s ongoing initiative to simplify and streamline operations the Company has identified core products on which to place its strategic focus. These core products consist of Reed’s and Virgil’s branded beverages. Non-core products consist primarily of candy and slower selling discontinued Reed’s and Virgil’s SKUs.

During 2023, the Company licensed its candy business to Rootstock Trading, a company founded and owned by our former Chief Sales Officer, Neal Cohane. As part of this agreement, Rootstock agrees to pay a royalty on a percentage of its net sales of licensed products. The royalty fees are 0% for 2023, 2% for 2024, 4% for 2025, and 5% thereafter.

Core beverage volume for the three months ended March 31, 2024, represents 100% of all beverage volume.

Core brand gross billing decreased by 16% to $10,377 compared to $12,333 during the same period last year, driven by a Reed’s volume decline of 6% and Virgil’s volume decline of 37%. The result is a decrease in total gross billing of 17%, to $10,379 during the three months ended March 31, 2024, from $12,453 in the same period last year. Price on our core brands increased 3% to $20.80 per case. The increase was a result of price increases across the channels of our product lines.

Discounts as a percentage of gross sales decreased to 8% from 10% in the same period last year. This decline in discounts partially offset the revenue decline. Net sales revenue decreased 14% in the three months ended March 31, 2024, to $9,595, compared to $11,157 in the same period last year.

Cost of Goods Sold

Cost of goods sold decreased $2,277 during the three months ended March 31, 2024, as compared to the same period last year. As a percentage of net sales, cost of goods sold for the three months ended March 31, 2023, was 64% as compared to 76% for the same period last year.

The total cost of goods per case increased to $12.39 per case in the three months ended March 31, 2024, from $13.80 per case for the same period last year. The cost of goods sold per case on core brands was $12.39 during the three months ended March 31, 2024, compared to $13.78 for the same period last year.

Gross Margin

Gross margin was 36% for the three months ended March 31, 2024, compared to 24% for the same period last year.

Operating Expenses

Delivery and Handling Expenses

Delivery and handling expenses consist of delivery costs to customers and warehousing costs incurred for handling our finished goods after production. Delivery and handling expenses decreased by $618 in the three months ended March 31, 2024, to $1,502 from $2,120 in the same period last year, driven by our efforts to mitigate inflationary costs. Delivery costs in the three months ended March 31, 2024, were 16% of net sales and $3.01 per case, compared to 19% of net sales and $3.46 per case during the same period last year.

Selling and Marketing Expenses

Marketing expenses consist of direct marketing, marketing labor, and marketing support costs. Selling expenses consist of all other selling-related expenses including personnel and contractor support. Total selling and marketing expenses were $1,093 during the three months ended March 31, 2024, compared to $1,447 during the same period last year. As a percentage of net sales, selling and marketing costs was 11% during the three months ended March 31, 2024, as compared to 13% during the same period last year. The decrease was primarily driven by lower employee related costs, marketing expenditures, and travel and entertainment expense, partially offset by slightly higher professional fees.

General and Administrative Expenses

General and administrative expenses consist primarily of the cost of executive, administrative, and finance personnel, as well as professional fees. General and administrative expenses decreased in the three months ended March 31, 2024, to $1,468 from $1,709, a decrease of $241 over the same period last year. As a percentage of net sales, general and administrative expenses were 15% during the three months ended March 31, 2024, as compared to 15% during the same period last year. The decrease was driven by lower employee related costs, professional fees, and stock compensation.

Loss from Operations

The loss from operations was $650 for the three months ended March 31, 2024, as compared to a loss of $2,578 in the same period last year driven by decreased gross profit offset by decreases in operating expenses discussed above.

Interest and Other Expense

Interest and other expense for the three months ended March 31, 2024, consisted of $1,023 of interest expense. During the same period last year, interest and other expense consisted of $1,779 of interest expense.

Modified EBITDA

In addition to our GAAP results, we present Modified EBITDA as a supplemental measure of our performance. However, Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus interest expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, legal settlements, and one-time restructuring-related costs including employee severance and asset impairment.

Management considers our core operating performance to be that which our managers can affect in any particular period through their management of the resources that affect our underlying revenue and profit generating operations during that period. Non-GAAP adjustments to our results prepared in accordance with GAAP are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Modified EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Modified EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

Set forth below is a reconciliation of net loss to Modified EBITDA for the three months ended March 31, 2024 and 2023 (unaudited; in thousands):

	Three Months Ended March 31
	2024			2023
Net loss	$	(1,673	)	$	(4,357	)

Modified EBITDA adjustments:
Depreciation and amortization		68			80
Tax expense		54
Interest expense		1,023			1,779
Product quality hold write-down		29
Stock option and other noncash compensation		129			233
Total EBITDA adjustments	$	1,303		$	2,092

Modified EBITDA	$	(370	)	$	(2,265	)

We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA has limitations as an analytical tool, which includes, among others, the following:

	●	Modified EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments;

	●	Modified EBITDA does not reflect changes in, or cash requirements for, our working capital needs;

	●	Modified EBITDA does not reflect future interest expense, or the cash requirements necessary to service interest or principal payments, on our debts; and

	●	Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Modified EBITDA does not reflect any cash requirements for such replacements.

Liquidity and Capital Resources

For the three months ended March 31, 2024, the Company recorded a net loss of $1,673 and used cash in operations of $2,395. In accordance with Accounting Standards Codification (“ASC”) 205-40, Going Concern, the Company’s management has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying financial statements were issued. As of the issuance date of these financial statements, management expects that the Company’s existing cash of $314, which includes $4,100 of additional cash received during the three months ended March 31, 2024, from investments with significant stockholders and expected cash flow from operations, will be sufficient to fund the Company’s current operating plan for at least twelve months from the date of issuance of these financial statements. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Management’s assessment whether there is sufficient cash on hand, together with expected capital raises, to assure operations for a period of at least twelve months from the date these financial statements are issued, is based on conditions that are known and reasonably knowable to management, considering various scenarios, projections, and estimates and certain key assumptions. These assumptions include, among other factors, management’s ability to raise additional capital, and the expected timing and nature of the Company’s forecasted cash expenditures.

Historically, the Company has financed its operations through public and private sales of common stock, convertible debt instruments, credit lines from financial institutions, and cash generated from operations. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.

Critical Accounting Policies and Estimates

The preparation of the Company’s financial statements in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of those judgments can be subjective and complex, and therefore, actual results could differ materially from those estimates under different assumptions or conditions. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates. Significant estimates include those related to assumptions used in estimates for reserves of uncollectible accounts, inventory obsolescence, depreciable lives of property and equipment, analysis of impairments of recorded long-term tangible and intangible assets, realization of deferred tax assets, accruals for potential liabilities and assumptions made in valuing stock instruments issued for services. There were no changes to our critical accounting policies described in the condensed financial statements included in our 2023 10-K that impacted our condensed financial statements and related notes included herein.

Recent Accounting Pronouncements

See Note 2 of the Notes to Condensed Financial Statements for a discussion of recent accounting pronouncements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

A smaller reporting company is not required to provide the information required by this Item.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of March 31, 2023, to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.

Changes in Internal Control Over Financial Reporting

There have been no changes in the Company’s internal control over financial reporting during the three months ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

We are subject to a variety of variety of litigation, claims, legal or regulatory proceedings, inquiries and investigations from time to time in the ordinary course of business. Management evaluates, and periodically re-evaluates, whether the final result of any of the foregoing may be expected to have a material adverse effect on our financial condition, results of operations or cash flows. Management has determined that no disclosure is required under this Item 1.

Item 1A. Risk Factors

Except as set forth below, there have been no material changes with respect to the risk factors disclosed in our 2023 Form 10-K.

Risks Related to Our Debt Service Obligations

Our ability to service our indebtedness will depend on our ability to generate cash in the future.

At March 31, 2024, our outstanding obligation on our 10% Secured Convertible Notes (“Notes”) was approximately $18.7 million and the balance on our ABL line of credit was approximately $8 million. Our Note holders have been amenable to making accommodations under the Notes by waiving conditions and financial covenants in exchange for certain negotiated penalties in lieu of declaring default. Our business may not generate sufficient cash to fund our working capital requirements, capital expenditure, debt service and other liquidity needs, which could result in our inability to comply with financial and other covenants contained in our debt agreements, our being unable to repay or pay interest and penalties on our indebtedness, and our inability to fund our other liquidity needs. If we are unable to service our debt obligations and maintain compliance with our financial and other covenants or, in the alternative, continue to negotiate suitable accommodations and fund our other liquidity needs, we could be forced to curtail our operations, our creditors could accelerate our indebtedness and exercise other remedies. We could be required to pursue one or more alternative strategies, such as selling assets or refinancing or restructuring our indebtedness. However, such alternatives may not be feasible or adequate.

Holders of our Notes have been amenable to making accommodations under the Notes by waiving conditions and financial covenants in exchange for certain negotiated penalties in lieu of declaring default. If do not meet our obligations under the Notes and are unable to negotiate accommodations in the future, the Note holders may declare a default, which would likely force us into bankruptcy.

At March 31, 2024, our outstanding obligation under the Notes was approximately $18.7 million. The Notes are secured by substantially all of the Company’s assets. The indebtedness under the Notes limits our growth, and management of the debt requires a significant amount of time and effort of our executive officers. While we have been successful negotiating waivers and amendments under the Notes, we may not be able to continue to do so in the future. We have further been exploring our options to refinance these Notes. If we are unable to service or repay these obligations at maturity and we are otherwise unable to extend the maturity dates or refinance these obligations, we may default. A default would trigger acceleration under the Notes, and it is unlikely that we would have sufficient funds to make these payments. Upon a default, the holders have the right to exercise their remedies to collect, including foreclosing on our assets. Accordingly, we would likely be forced to seek bankruptcy protection in the event of default.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None that have not been previously disclosed in a Current Report on Form 8-K.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Item 6. Exhibits

See Exhibit Index on page. [8].

INDEX TO EXHIBITS

ITEM 15(a)(3)

The following is a list of the exhibits filed as part of this Form 10-Q. The documents incorporated by reference can be viewed on the SEC’s website at http://www.sec.gov.

Exhibit

3(i)	Certificate of Incorporation of Reeds, Inc. which is incorporated herein by reference to exhibit 3(iv) to Form 10-K filed with SEC on May 15, 2023.
3(ii)	Amended and Restated Bylaws of Reed’s, Inc. which is incorporated by reference to Exhibit 3.8 to Form 10-K/A filed with the SEC on April 8, 2020.
4.1	Simple Agreement for Future Equity by and between Reed’s, Inc. and D&D Source of Life Holding Ltd. dated February 8, 2024 which is incorporated by reference to Exhibit 4.7 to Form 10-K as filed with the SEC on April 1, 2024.
4.2	Simple Agreement for Future Equity by and between Reed’s, Inc. and John J. Bello dated March 7, 2024 which is incorporated by reference to Exhibit 4.8 to Form 10-K as filed with the SEC on April 1, 2024.
4.3	Simple Agreement for Future Equity by and between Reed’s, Inc. and Union Square Park Partners LP dated February 8, 2024 which is incorporated by reference to Exhibit 4.9 to Form 10-K as filed with the SEC on April 1, 2024.
10.1	Limited Waiver, Deferral, and Amendment and Restatement Agreement by and between Reed’s, Inc. and each holder and Wilmington Savings Fund Society, FSB, holder representative and collateral agent dated February 12, 2024 which is incorporated by reference to Exhibit 10.3 to Form 8-K as filed with the SEC February 13, 2024.
10.2	Amendment to Limited Waiver, Deferral, and Amendment and Restatement Agreement by and between Reed’s, Inc. and each holder and Wilmington Savings Fund Society, FSB, holder representative and collateral agent dated April 1, 2024 which is incorporated by reference to Exhibit 10.1 to Form 8-K/A as filed with the SEC on April 3, 2024.
10.3	Limited Waiver and Deferral Agreement by and between Reed’s, Inc. and each holder and Wilmington Savings Fund Society, FSB, holder representative and collateral agent dated May 17, 2024.
31	Certification of our Chief Executive Officer and our Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32	Certification of our Chief Executive Officer and our Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	The following materials from Reed’s, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Balance Sheets, (ii) the Condensed Statements of Operations, (iii) the Condensed Statements of Changes in Stockholders (Deficit), (iv) the Condensed Statements of Cash Flows, and (v) Notes to Condensed Financial Statements.
104	The cover page from the Reed’s, Inc. Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, formatted in Inline XBRL and contained in Exhibit 101.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Reed’s, Inc. (Registrant)

Date: May 20, 2024	/s/ Norman E. Snyder, Jr.
	Norman E. Snyder, Jr.
	Chief Executive Officer
	(Principal Executive Officer)

Date: May 20, 2024	/s/ Joann Tinnelly
	Joann Tinnelly
	Chief Financial Officer
	(Principal Financial Officer)

Exhibit 10.3

LIMITED WAIVER AND DEFERRAL AGREEMENT

THIS LIMITED WAIVER AND DEFERRAL AGREEMENT (this “Waiver”) is dated and effective as of May 17, 2024 between REED’S, INC., a Delaware corporation (the “Company”), the Holders party hereto, and WILMINGTON SAVINGS FUND SOCIETY, FSB, as Holder Representative and Collateral Agent (the “Agent”).

WHEREAS, on May 9, 2022, the Company, the Holder Representative and each purchaser on the schedule of purchasers thereto entered into that certain Note Purchase Agreement, (as amended, the “Note Purchase Agreement”), pursuant to which the Company issued 10% Secured Convertible Notes, (as amended each, a “Note”, and collectively, the “Notes”), and as of the date hereof, the outstanding Notes include Note No. 1, Note No. 2, Note No. 3 and Note No. 4 (the “Original Notes”) and Note No. 9, Note No. 10, Note No. 11, Note No. 12, Note No. 13, Note No. 14, Note No. 15 and Note No. 16 (the “Option Notes”).

WHEREAS, on February 10, 2023, the Company, the Holders and the Agent entered into a Limited Waiver and Deferral Agreement (the “February 2023 Limited Waiver”), pursuant to which the parties agreed to, among other things, (i) waive certain provisions of the Notes relating to a Fundamental Change resulting from a delisting of the Common Stock, (ii) waiving certain Events of Default, (iii) foregoing certain Amortization Payments through June 30, 2023 and (iv) deferring certain fees payable under the Notes with regard to the Indebtedness of the ABL Lenders arising under the ABL Debt Documents at each calendar month end exceeding the applicable amount set forth in clause (n) of the definition of Permitted Indebtedness.

WHEREAS, on April 11, 2023, the Company, the Holders and the Agent entered into a Limited Waiver, pursuant to which the parties agreed to further waive certain provisions of the Notes relating to the Fundamental Change resulting from the delisting of the Common Stock from the Nasdaq Stock Market (the “Delisting”).

WHEREAS, on May 30, 2023, the Company, the Holders and the Agent entered into a Limited Waiver and Deferral Agreement (the “May 2023 Limited Waiver”), pursuant to which the parties agreed to, among other things, (i) further defer the Deferred ABL Fees (as defined in the February 2023 Limited Waiver) to September 29, 2023, and (ii) rescind the Holders’ election to receive monthly Amortization Payments otherwise due and payable during the period from December 1, 2022 until September 29, 2023.

WHEREAS, on October 5, 2023, the Company, the Holders and the Agent entered into a Limited Waiver and Deferral Agreement (the “October 2023 Limited Waiver”), pursuant to which the parties agreed to, among other things, (i) further defer the Updated Deferred ABL Fees (as defined in the October 2023 Limited Waiver) to November 28, 2023, and (ii) rescind the Holders’ election to receive monthly Amortization Payments otherwise due and payable during the period from December 1, 2022 until October 31, 2023.

WHEREAS, on February 12, 2024, the Company, the Holders and the Agent entered into a Limited Waiver, Deferral and Amendment and Restatement Agreement (as such agreement was subsequently amended, the “A&R Agreement”), pursuant to which the parties agreed to, among other things, (i) waive certain Defaults and Events of Default with respect to the Notes and (ii) subject to the satisfaction of certain conditions precedent (the “A&R Conditions Precedent”), to amend and restate the Notes and to equitize certain interest and fees owing on the Notes as set forth in the A&R Agreement.

WHEREAS, the A&R Conditions Precedent were never satisfied (and as a result the A&R Effective Date (as defined in the A&R Agreement) never occurred) and the waivers provided by the A&R Agreement have expired.

WHEREAS, the Company (i) has paid all accrued and unpaid Cash Interest (other than Default Interest (as defined below)) on the Original Notes through May 9, 2024 and (ii) assuming the satisfaction of the conditions set forth in Section 6 of this Waiver, will have paid all accrued and unpaid Cash Interest (other than Default Interest) on the Option Notes through April 30, 2024.

NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration (the receipt and sufficiency of which is hereby acknowledged), the parties hereto, intending to be legally bound hereby, agree as follows:

1. Incorporation of Terms. All capitalized terms not otherwise defined herein shall have the same meaning as in the Notes.

2. Representations and Warranties. The Company hereby represents and warrants that after giving effect to this Waiver, all representations and warranties contained in the Notes are true and correct, in all material respects, on and as of the date hereof, except (a) to the extent that such representations and warranties specifically refer to an earlier date, in which case they shall be true and correct as of such earlier date, and (b) in the case of any representation and warranty qualified by materiality, they shall be true and correct in all respects.

3. Waivers.

(a) Subject to the satisfaction of the conditions precedent set forth in Section 6 of this Waiver, Agent (as directed by all Holders below) and the Holders party hereto hereby temporarily waive the Specified Events of Default under the Notes (as listed on Annex A hereto) through and including the earlier to occur of (i) the date that any Event of Default (other than a Specified Event of Default) occurs under the Notes or any other Note Document and (ii) June 10, 2024 (such period, the “Waiver Period”).

(b) Except as set forth in Section 3(a), in the event that the Specified Events of Default have not been resolved in a manner acceptable to the Majority Holders on or before the expiration of the applicable Waiver Period, (i) the waiver provided in Section 3(a) shall terminate immediately, and (ii) the Specified Events of Default shall be deemed to have occurred and be continuing for all purposes of the Notes and the other Note Documents.

(c) Subject to the satisfaction of the conditions precedent set forth in Section 6 of this Waiver, Agent (as directed by all Holders below) and the Holders party hereto hereby temporarily waive any requirement pursuant to Section 6 of the Notes that the Company conduct a repurchase of Notes as a result of the Delisting prior to June 10, 2024, provided, that, for all purposes under the Notes, the Company shall treat the Delisting, and the resulting Fundamental Change and Make-Whole Fundamental Change, as if they occurred and became effective on and as of June 10, 2024.

(d) This Section 3 shall be effective only to the extent specifically set forth herein and shall not be construed as a consent to or waiver of any breach or Default other than as specifically waived herein and shall not (i) affect the right of Agent or any of the Holders to demand strict compliance by Company with all terms and conditions of the Notes, except as specifically consented to, modified or waived by the terms hereof, (ii) be deemed a consent to or waiver of any future transaction or action on the part of any Note Party requiring the Holders’ or the Majority Holders’ consent or approval under the Notes, or (iii) diminish, prejudice or waive any of Agent’s or any Holders’ rights and remedies under the Notes or applicable law, whether arising as a consequence of any Event of Default which may now exist or otherwise, and Agent and each of the Holders hereby reserve all of such rights and remedies. For the avoidance of doubt and notwithstanding anything herein to the contrary, to the extent any provision of the Notes is qualified by, or requires the absence of, any Default or Event of Default, a Default or Event of Default shall be deemed to not have occurred for purposes of such provisions.

4. Certain ABL Fees, Conversion/PIK Schedule and Default Interest.

(a) Certain ABL Fees and Amortization. Subject to the satisfaction of the conditions precedent set forth in Section 6 of this Waiver:

(i) Notwithstanding anything to the contrary in the February 2023 Limited Waiver, the May 2023 Limited Waiver, the October 2023 Limited Waiver, the A&R Agreement or Section 12(g) of the Notes, the Updated Deferred ABL Fees (as defined in the October 2023 Limited Waiver) and any fee payable pursuant to Section 12(g) of the Notes between November 28, 2023 and June 10, 2024, shall become due and payable in cash on June 10, 2024. The Company and the Holders acknowledge and agree that a complete listing of all fees payable pursuant to Section 12(g) of the Notes as of the date hereof is set forth on Annex B hereto.

(ii) Notwithstanding anything to the contrary in Section 2(b) of the Notes, (i) the Holders agree to rescind their election to receive monthly Amortization Payments otherwise due and payable during the period from December 1, 2023 until June 30, 2024 (the “Foregone Amortization Payments”), (ii) the applicable portion of the aggregate Principal Amounts included in the Foregone Amortization Payments shall remain part of the aggregate Principal Amount of the applicable Note outstanding and shall become due and owing in accordance with the terms of such Notes and (iii) Interest shall continue to accrue on such Principal Amounts without interruption (which interest, in the case of all periods from, and including, December 1, 2023 shall include Default Interest (as defined below) as contemplated by Section 2(a) of the Notes and Section 4(c) of this Waiver). The Company and Holders hereby acknowledge and agree that Amortization Payments shall resume on July 1, 2024. The Company and Holders hereby acknowledge and agree that the updated amortization schedule is, as of the date hereof, true and accurate as set forth on Annex C hereto. For the avoidance of doubt, such updated amortization schedule has been calculated without consideration of any Default Interest paid or payable after the date hereof as contemplated by Section 2(a) of the Notes and Section 4(c) of this Waiver.

(b) Conversion/PIK Schedule. The Company and Holders hereby acknowledge and agree that the Conversion/PIK Schedule in respect of each of the Original Notes is, as of the date hereof, true and accurate as set forth on Annex D hereto.

(c) Default Interest. Regardless whether any of the conditions set forth in Section 6 of this Waiver have been satisfied, the Company acknowledges and agrees that, consistent with the A&R Agreement, all outstanding Obligations under the Notes continue to bear interest, payable whenever Interest is otherwise payable pursuant to the notes, at the rate otherwise applicable thereto plus 2.00% per annum (“Default Interest”), and that such Default Interest is payable notwithstanding the absence of any Defaults or Events of Default as a result of the waivers provided pursuant to this Waiver. The parties acknowledge and agree that (i) through May 9, 2024, cash Default Interest totaling $48,797.58 was accrued and unpaid with respect to the Original Notes and (ii) through April 30, 2024, cash Default Interest totaling $33,750.21 was accrued and unpaid with respect to the Option Notes.

5. Releases.

(a) The Company, on behalf of itself and each of the Note Parties (and on behalf of each Affiliate thereof) and for itself and for its successors in title and assignees and, to the extent the same is claimed by right of, through or under any of the Note Parties, for its past, present and future employees, agents, representatives (other than legal representatives), officers, directors, shareholders, and trustees (each, a “Releasing Party” and collectively, the “Releasing Parties”), does hereby remise, release and discharge, and shall be deemed to have forever remised, released and discharged, the Agent, and each of the Holders in their respective capacities as such under the Note Documents, and the Agent’s and each Holder’s respective successors-in-title, legal representatives and assignees, past, present and future officers, directors, affiliates, shareholders, trustees, agents, employees, consultants, experts, advisors, attorneys and other professionals and all other persons and entities to whom the Agent and each of the Holders or any of their respective successors-in-title, legal representatives and assignees, past, present and future officers, directors, affiliates, shareholders, trustees, agents, employees, consultants, experts, advisors, attorneys and other professionals would be liable if such persons or entities were found to be liable to any Releasing Party or any of them (collectively, hereinafter the “Releasees”), from any and all manner of action and actions, cause and causes of action, claims, charges, demands, counterclaims, crossclaims, suits, debts, dues, sums of money, accounts, reckonings, bonds, bills, specialties, covenants, contracts, rights of setoff and recoupment, controversies, damages, judgments, expenses, executions, liens, claims of liens, claims of costs, penalties, attorneys’ fees, or any other compensation, recovery or relief on account of any liability, obligation, demand or cause of action of whatever nature, whether in law, equity or otherwise, whether known or unknown, fixed or contingent, joint and/or several, secured or unsecured, due or not due, primary or secondary, liquidated or unliquidated, contractual or tortious, direct, indirect, or derivative, asserted or unasserted, foreseen or unforeseen, suspected or unsuspected, now existing, heretofore existing or which may heretofore accrue against any of the Releasees, and which are, in each case, based on any act, fact, event or omission or other matter, cause or thing occurring at any time prior to or on the date hereof in any way, directly or indirectly arising out of, connected with or relating to the Notes or any other Note Document and the transactions contemplated thereby, and all other agreements, certificates, instruments and other documents and statements (whether written or oral) related to any of the foregoing (each, a “Claim” and collectively, the “Claims”); provided, that, no Releasing Party shall have any obligation with respect to Claims to the extent such Claims are determined by a court of competent jurisdiction by final and non-appealable judgment to have resulted from the gross negligence or willful misconduct of any Releasee. Each Releasing Party further stipulates and agrees with respect to all Claims, that it hereby waives, to the fullest extent permitted by applicable law, any and all provisions, rights, and benefits conferred by any applicable U.S. federal or state law, or any principle of common law, that would otherwise limit a release or discharge of any unknown Claims pursuant to this Section 5.

(b) The Company, on behalf of each Note Party, itself and its successors, assigns, and other legal representatives, hereby absolutely, unconditionally and irrevocably, covenants and agrees with and in favor of each Releasee that it will not sue (at law, in equity, in any regulatory proceeding or otherwise) any Releasee on the basis of any Claim released, remised and discharged by any Note Party pursuant to Section 5(a) of this Waiver. If any Note Party or any of its successors, assigns or other legal representatives violates the foregoing covenant, the Note Parties, each for itself and its successors, assigns and legal representatives, agrees to pay, in addition to such other damages as any Releasee may sustain as a result of such violation, all attorneys’ fees and costs incurred by any Releasee as a result of such violation.

6. Conditions to Effectiveness. This Waiver shall not be effective until each of the following conditions precedent has been fulfilled to the satisfaction of the Agent (at the direction of all Holders):

(a) This Waiver shall have been duly executed and delivered by the Company, the Agent, and the Majority Holders, and the Agent shall have received evidence thereof.

(b) After giving effect to this Waiver, no Default or Event of Default shall have occurred and be continuing.

(c) The Company shall have paid (i) all accrued and unpaid Interest (other than Default Interest) as of April 30, 2024 on the Option Notes, totaling $39,781.33, (ii) all outstanding fees and expenses of King & Spalding LLP, counsel to the Holders, and (iii) all outstanding fees and expenses of Chapman and Cutler LLP, counsel to the Agent.

7. Binding Effect. The terms and provisions hereof shall be binding upon and inure to the benefit of the parties hereto and their heirs, representatives, successors and assigns.

8. Reaffirmation of Obligations. The Company hereby ratifies the Note Documents and acknowledges and reaffirms (a) that it is bound by all terms of the Note Documents applicable to it and (b) that it is responsible for the observance and full performance of its respective Obligations.

9. Note Document. This Waiver shall constitute a Note Document under the terms of each Note.

10. Multiple Counterparts. This Waiver may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this Waiver by telecopy, pdf or other electronic transmission shall be as effective as delivery of a manually executed counterpart of this Waiver.

11. Governing Law. THIS WAIVER AND ANY CLAIMS, CONTROVERSY, DISPUTE OR CAUSE OF ACTION, WHETHER IN LAW OR EQUITY, WHETHER IN CONTRACT OR IN TORT OR OTHERWISE BASED UPON, ARISING OUT OF OR RELATING TO THIS WAIVER AND THE TRANSACTIONS CONTEMPLATED HEREBY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.

12. Consent to Jurisdiction; Service of Process; Agreement of Jury Trial. The jurisdiction, service of process and waiver of jury trial provisions set forth in subsections 13(h) and 13(i) of the Notes are hereby incorporated by reference.

13. Agent Authorization. Each of the undersigned Holders hereby authorizes and directs Agent to execute and deliver this Waiver on its behalf and, by its execution below, each of the undersigned Holders agrees to be bound by the terms and conditions of this Waiver. In executing this Waiver, the Agent shall be entitled to all of the rights, benefits, protections, indemnities and immunities afforded to it pursuant to the Note Documents.

[Signature page follows]

IN WITNESS WHEREOF, this Limited Waiver and Deferral Agreement has been duly executed and delivered by each of the parties hereto as of the date first above written.

COMPANY:		HOLDER REPRESENTATIVE:

Reed’s, Inc.		Wilmington Savings Fund Society, FSB, solely in its capacity as the Holder Representative

By:	/s/ Norman E. Snyder, Jr.	By:	/s/ Raye Goldsborough
Name:	Norman E. Snyder, Jr	Name:	Raye Goldsborough
Title:	CEO	Title:	Vice President

HOLDERS:		COLLATERAL AGENT:

Whitebox Multi-Strategy Partners, LP		Wilmington Savings Fund Society, FSB, solely in its capacity as the Collateral Agent

By:	/s/ Andrew Thau	By:	/s/ Raye Goldsborough
Name:	Andrew Thau	Name:	Raye Goldsborough
Title:	Authorized Signatory	Title:	Vice President

Whitebox Relative Value Partners, LP

By:	/s/ Andrew Thau
Name:	Andrew Thau
Title:	Authorized Signatory

Pandora Select Partners, LP

By:	/s/ Andrew Thau
Name:	Andrew Thau
Title:	Authorized Signatory

Whitebox GT Fund, LP

By:	/s/ Andrew Thau
Name:	Andrew Thau
Title:	Authorized Signatory

[Signature Page to Limited Waiver]

Annex A to

Limited Waiver and Deferral Agreement

Specified Events of Default

	1.	The Company’s failure to comply with Section 4(f) of the Notes on or prior to the date hereof.

	2.	The Company’s failure to comply with Section 7(w) of the Notes on or prior to the date hereof by maintaining Indebtedness in favor of the ABL Lenders arising under the ABL Debt Documents that exceeds the amount permitted by clause (n) of the definition of Permitted Indebtedness in the Notes.

	3.	The Company’s failure to comply with Section 7(kk) of the Notes on or prior to the date hereof.

	4.	The Company’s failure to timely pay on or prior to the date hereof (a) the Principal Amount as required by Section 2(a) of each Option Note at their maturity, (b) any Cash Interest (including Default Interest) as required by Section 2(d) of each Option Note, (c) the Principal Amount of any amortization payment pursuant to Section 2(b) of each Original Note and (d) any Cash Interest or PIK Interest (including Default Interest) as required by Section 2(d) of each Original Note.

	5.	The Company’s failure to timely pay (a) on or prior to the date hereof the Amortization Payments due on December 1, 2023, January 1, 2024, February 1, 2024, March 1, 2024, April 1, 2024 and May 1, 2024 as required by Section 2(b) of the Notes, or (b) on or prior to the date hereof the Excess ABL Fee as required under Section 12(g) of the Notes.

Annex B to

Limited Waiver and Deferral Agreement

ABL Fees

Fees payable pursuant to Section 12(g) with respect to Indebtedness in favor of the ABL Lenders arising under the ABL Debt Documents for the month ending as of each date listed below:

Date

Excess ABL Fee

[OMITTED]

Annex C to

Limited Waiver and Deferral Agreement

Updated Amortization Schedule

(Calculated without giving effect to Default Interest occurring after the date hereof)

See Attached

[OMITTED]

Annex D to

Limited Waiver and Deferral Agreement

Conversion / PIK Schedules

See attached.

[OMITTED]

EXHIBIT 31

Certification of Principal Executive Officer

I, Norman E. Snyder, Jr., certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Reed’s, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s first fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 20, 2024

/s/ Norman E. Snyder, Jr.

Name: Norman E. Snyder, Jr.

Title: Chief Executive Officer

(Principal Executive Officer)

Certification of Principal Financial Officer

I, Joann Tinnelly, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Reed’s, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 20, 2024

/s/ Joann Tinnelly

Name: Joann Tinnelly

Title: Chief Financial Officer

(Principal Financial Officer)

EXHIBIT 32

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Norman E. Snyder, Jr., the Chief Executive Officer of Reed’s, Inc. (the “Company”), hereby certify, that, to my knowledge:

1. The Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024 (the “Report”) of the Company fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 20, 2024

/s/ Norman E. Snyder, Jr.

Name: Norman E. Snyder, Jr.

Title: Chief Executive Officer

(Principal Executive Officer)

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Joann Tinnelly, the Chief Financial Officer of Reed’s, Inc. (the “Company”), hereby certify, that, to my knowledge:

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 20, 2024

/s/ Joann Tinnelly

Name: Joann Tinnelly

Title: Chief Financial Officer

(Principal Financial Officer)

Cover - shares	3 Months Ended
Cover - shares	Mar. 31, 2024	May 10, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	001-32501
Entity Registrant Name	REED’S, INC.
Entity Central Index Key	0001140215
Entity Tax Identification Number	35-2177773
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	201 Merritt 7
Entity Address, City or Town	Norwalk
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06851
City Area Code	(800)
Local Phone Number	997-3337
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		4,187,291

Condensed Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash	$ 314	$ 603
Accounts receivable, net of allowance of $258 and $860, respectively	3,251	3,571
Inventory	12,017	11,300
Prepaid expenses and other current assets	2,332	2,028
Total current assets	18,178	17,761
Property and equipment, net of accumulated depreciation of $1,136 and $1,068, respectively	441	493
Intangible assets	631	629
Total assets	19,250	18,883
Current liabilities:
Accounts payable	8,484	9,133
Accrued expenses	872	1,096
Revolving line of credit, net of capitalized financing costs of $161 and $201, respectively	7,844	9,758
Current portion of convertible notes payable, net of debt discount of $509 and $424, respectively	7,339	6,737
Current portion of lease liabilities	155	207
Total current liabilities	25,025	27,190
SAFE agreements	4,097
Convertible note payable, net of debt discount of $45 and $148, respectively, less current portion	10,853	10,874
Total liabilities	39,975	38,064
Stockholders’ deficit:
Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 9,411 shares issued and outstanding	94	94
Common stock, $.0001 par value, 180,000,000 shares authorized; 4,187,291 and 4,187,291 shares issued and outstanding, respectively
Additional paid in capital	119,581	119,452
Accumulated deficit	(140,400)	(138,727)
Total stockholders’ deficit	(20,725)	(19,181)
Total liabilities and stockholders’ deficit	19,250	18,883
Related Party [Member]
Current assets:
Receivable from former related party	264	259
Current liabilities:
Payable to former related party	$ 331	$ 259

Condensed Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Accounts receivable, net of allowance	$ 258	$ 860
Property and equipment, accumulated depreciation	1,136	1,068
Capitalized financing costs	161	201
Debt discount current	509	424
Debt discount, noncurrent	$ 45	$ 148
Series A convertible preferred stock, par value	$ 10	$ 10
Series A convertible preferred stock, shares authorized	500,000	500,000
Series A convertible preferred stock, shares issued	9,411	9,411
Series A convertible preferred stock, shares outstanding	9,411	9,411
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	180,000,000	180,000,000
Common stock, shares issued	4,187,291	4,187,291
Common stock, shares outstanding	4,187,291	4,187,291

Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net Sales	$ 9,595	$ 11,157
Cost of goods sold	6,182	8,459
Gross profit	3,413	2,698
Operating expenses:
Delivery and handling expense	1,502	2,120
Selling and marketing expense	1,093	1,447
General and administrative expense	1,468	1,709
Total operating expenses	4,063	5,276
Loss from operations	(650)	(2,578)
Interest expense	(1,023)	(1,779)
Net loss	$ (1,673)	$ (4,357)
Net loss per share - basic	$ (0.40)	$ (1.70)
Net loss per share - diluted	$ (0.40)	$ (1.70)
Weighted average number of shares outstanding - basic	4,187,291	2,559,855
Weighted average number of shares outstanding - diluted	4,187,291	2,559,855

Condensed Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2022		$ 94	$ 114,635	$ (123,199)	$ (8,470)
Balance, shares at Dec. 31, 2022	2,519,485	9,411
Fair value of vested options			229		229
Net loss				(4,357)	(4,357)
Fair value of vested restricted shares granted to officers			4		4
Fair value of vested restricted shares granted to officers, shares	750
Repurchase of common stock			(1)		(1)
Repurchase of common stock, shares	(274)
Common shares issued for financing costs			273		273
Common shares issued for financing costs, shares	82,438
Balance at Mar. 31, 2023		$ 94	115,140	(127,556)	(12,322)
Balance, shares at Mar. 31, 2023	2,602,399	9,411
Balance at Dec. 31, 2023		$ 94	119,452	(138,727)	(19,181)
Balance, shares at Dec. 31, 2023	4,187,291	9,411
Fair value of vested options			129		129
Stock Issued During Period, Value, New Issues
Net loss				(1,673)	(1,673)
Balance at Mar. 31, 2024		$ 94	$ 119,581	$ (140,400)	$ (20,725)
Balance, shares at Mar. 31, 2024	4,187,291	9,411

Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net loss	$ (1,673)	$ (4,357)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation	29	47
Amortization of debt discount	144	281
Fair value of vested options	129	229
Fair value of vested restricted shares granted to officers		4
Change in allowance for doubtful accounts	(601)	(39)
Inventory write-downs	(783)	(228)
Accrued interest	564	1,113
Changes in operating assets and liabilities:
Accounts receivable	922	1,044
Inventory	66	1,102
Prepaid expenses and other assets	(1,305)	338
Decrease in right of use assets	39	32
Accounts payable	351	1,360
Accrued expenses	(225)	235
Lease liabilities	(52)	(44)
Net cash provided by (used in) operating activities	(2,395)	1,117
Cash flows from investing activities:
Trademark costs	(2)
Purchase of property and equipment	(16)
Net cash used in investing activities	(18)
Cash flows from financing activities:
Proceeds from line of credit	8,285	8,699
Payments on line of credit	(10,239)	(12,120)
Proceeds from convertible note payable, net of expenses		2,405
Proceeds from SAFE agreement	4,097
Payment of cost recorded as debt discount	(86)
Repurchase of common stock		(1)
Amounts from former related party, net	67	(166)
Net cash provided by (used in) financing activities	2,124	(1,183)
Net increase (decrease) in cash	(289)	(66)
Cash at beginning of period	603	533
Cash at end of period	314	467
Supplemental disclosures of cash flow information:
Cash paid for interest	318	390
Non-cash investing and financing activities:
Reclass of prepaid expenses and accounts payable	$ 1,000	$ 0

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

1. Summary of Significant Accounting Policies

Basis of Presentation

The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2024.

Liquidity

Recent Trends - Market Conditions

Use of Estimates

Revenue Recognition

Loss per Common Share

	March 31, 2024		March 31, 2023
Warrants		549,292		235,946
Options		141,869		174,460
Convertible note payable		1,557,066		1,257,491
Unvested restricted common stock		-		710
Common stock equivalent of Series A Convertible Preferred stock		753		753
Total		2,248,980		1,669,360

Stock Compensation Expense

Advertising Costs

Concentrations

Fair Value of Financial Instruments

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.

Level 3—Unobservable inputs based on the Company’s assumptions.

Reclassifications

Recent Accounting Pronouncements

Inventory

3 Months Ended

Mar. 31, 2024

Inventory Disclosure [Abstract]

Inventory

2. Inventory

Inventory is valued at the lower of cost (first-in, first-out) or net realizable value, net of write downs, and is comprised of the following (in thousands):

Schedule of Inventory

	March 31, 2024		December 31, 2023
Raw materials and packaging	$	6,766	$	6,445
Finished products		5,251		4,855
Total	$	12,017	$	11,300

Property and Equipment

3 Months Ended

Mar. 31, 2024

Property, Plant and Equipment [Abstract]

Property and Equipment

3. Property and Equipment

Property and equipment are comprised of the following (in thousands):

Schedule of Property and Equipment

	March 31, 2024			December 31, 2023
Right-of-use assets under operating leases	$	724		$	724
Computer hardware and software		400			400
Machinery and equipment		352			352
Construction in progress		101			85
Total cost		1,577			1,561
Accumulated depreciation and amortization		(1,136	)		(1,068	)
Net book value	$	441		$	493

Intangible Assets

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

4. Intangible Assets

Intangible assets consist of the following (in thousands):

Summary of Intangible Assets

	March 31, 2024		December 31, 2023
Brand names	$	576	$	576
Trademarks		55		53
Total	$	631	$	629

Line of Credit

3 Months Ended

Mar. 31, 2024

Line Of Credit

Line of Credit

5. Line of Credit

The Company’s credit facility consisted of the following (in thousands):

	March 31, 2024			December 31, 2023
Line of credit – Alterna Capital Solutions	$	8,005		$	9,959
Less: capitalized financing costs		(161	)		(201	)
Total	$	7,844		$	9,758

Secured Convertible Notes Payable

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Secured Convertible Notes Payable

6. Secured Convertible Notes Payable

Amounts outstanding under the Company’s convertible notes payable are as follows (amounts in 000’s except share amounts):

	March 31, 2024			December 31, 2023
Secured Convertible “Original” Notes Payable (A)	$	10,250		$	10,250
Secured Convertible “Option”” Notes Payable (B)		4,050			4,050
Secured Convertible “Option”” Notes Payable		4,050			4,050
Accrued interest		1,457			1,059

Accrued interest on excess debt borrowing		2,989			2,824
Capitalized financing costs		(554	)		(572	)
Total	$	18,192		$	17,611

Secured Convertible Notes

(A)

(B)

Waiver of Default

Accrued Interest

Debt Discount

Leases Liabilities

3 Months Ended

Mar. 31, 2024

Leases [Abstract]

Leases Liabilities

7. Leases Liabilities

During the three months ended March 31, 2024 and 2023, lease costs totaled $39 and $32, respectively.

As of March 31, 2024, the weighted average remaining lease terms for an operating lease are 0.75 years. As of March 31, 2024, the weighted average discount rate on the operating lease is 12.60%.

Simple Agreements for Future Equity (“SAFE”) Investments

3 Months Ended

Mar. 31, 2024

Equity [Abstract]

Simple Agreements for Future Equity (“SAFE”) Investments

8. Simple Agreements for Future Equity (“SAFE”) Investments

Stock-Based Compensation

3 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement [Abstract]

Stock-Based Compensation

9. Stock-Based Compensation

Stock Options

The following table summarizes stock option activity during the three months ended March 31, 2024:

Schedule of Stock Option Activity

	Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Terms (Years)		Aggregate Intrinsic Value
Outstanding at December 31, 2023		145,012		$	45.09		6.75	$	-
Granted		-		$	-
Exercised		-		$	-
Unvested forfeited		-		$	-
Vested forfeited		(3,143	)	$	45.05
Outstanding at March 31, 2024		141,869		$	44.03		6.50	$	-
Exercisable at March 31, 2024		111,583		$	51.09		6.07	$	-

Stock Warrants

3 Months Ended

Mar. 31, 2024

Stock Warrants

Stock Warrants

10. Stock Warrants

The Company’s warrant activity during the three months ended March 31, 2024 is as follows:

Schedule of Warrant Activity

	Shares		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Terms (Years)		Aggregate Intrinsic Value

Outstanding at December 31, 2023		549,292	$	8.77		2.84	$	-
Granted		-		-		-
Exercised		-		-		-
Forfeited		-		-		-
Outstanding at March 31, 2024		549,292	$	8.77		2.59	$	-
Exercisable at March 31, 2024		549,292	$	8.77		2.59	$	-

Transactions with California Custom Beverage, LLC, former related party

3 Months Ended

Mar. 31, 2024

Transactions with California Custom Beverage, LLC, former related party

11. Transactions with California Custom Beverage, LLC, former related party

At March 31, 2024 and 2023, accounts receivable due from and accounts payable due to CCB were as follows:

Schedule of Related Parties

	March 31, 2024			December 31, 2023
Accounts receivable, net of provision of $1,123 and $1,123 at March 31, 2024 and December 31, 2023, respectively		264			259
Accounts payable		(331	)		(259	)
Net (payable) receivable		(67	)		-

Commitments and Contingencies

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

12. Commitments and Contingencies

Subsequent Events

3 Months Ended

Mar. 31, 2024

Subsequent Events [Abstract]

Subsequent Events

13. Subsequent Events

Secured Convertible Notes Payable

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2024.

Liquidity

Liquidity

Recent Trends - Market Conditions

Recent Trends - Market Conditions

Use of Estimates

Use of Estimates

Revenue Recognition

Revenue Recognition

Loss per Common Share

Loss per Common Share

	March 31, 2024		March 31, 2023
Warrants		549,292		235,946
Options		141,869		174,460
Convertible note payable		1,557,066		1,257,491
Unvested restricted common stock		-		710
Common stock equivalent of Series A Convertible Preferred stock		753		753
Total		2,248,980		1,669,360

Stock Compensation Expense

Stock Compensation Expense

Advertising Costs

Advertising Costs

Concentrations

Concentrations

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.

Level 3—Unobservable inputs based on the Company’s assumptions.

Reclassifications

Reclassifications

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Schedule of Potentially Dilutive Securities

	March 31, 2024		March 31, 2023
Warrants		549,292		235,946
Options		141,869		174,460
Convertible note payable		1,557,066		1,257,491
Unvested restricted common stock		-		710
Common stock equivalent of Series A Convertible Preferred stock		753		753
Total		2,248,980		1,669,360

Inventory (Tables)

3 Months Ended

Mar. 31, 2024

Inventory Disclosure [Abstract]

Schedule of Inventory

Inventory is valued at the lower of cost (first-in, first-out) or net realizable value, net of write downs, and is comprised of the following (in thousands):

Schedule of Inventory

	March 31, 2024		December 31, 2023
Raw materials and packaging	$	6,766	$	6,445
Finished products		5,251		4,855
Total	$	12,017	$	11,300

Property and Equipment (Tables)

3 Months Ended

Mar. 31, 2024

Property, Plant and Equipment [Abstract]

Schedule of Property and Equipment

Property and equipment are comprised of the following (in thousands):

Schedule of Property and Equipment

	March 31, 2024			December 31, 2023
Right-of-use assets under operating leases	$	724		$	724
Computer hardware and software		400			400
Machinery and equipment		352			352
Construction in progress		101			85
Total cost		1,577			1,561
Accumulated depreciation and amortization		(1,136	)		(1,068	)
Net book value	$	441		$	493

Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of Intangible Assets

Intangible assets consist of the following (in thousands):

Summary of Intangible Assets

	March 31, 2024		December 31, 2023
Brand names	$	576	$	576
Trademarks		55		53
Total	$	631	$	629

Line of Credit (Tables)

3 Months Ended

Mar. 31, 2024

Line Of Credit

Schedule of Amount Outstanding Under Credit Facilities

The Company’s credit facility consisted of the following (in thousands):

	March 31, 2024			December 31, 2023
Line of credit – Alterna Capital Solutions	$	8,005		$	9,959
Less: capitalized financing costs		(161	)		(201	)
Total	$	7,844		$	9,758

Secured Convertible Notes Payable (Tables)

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Schedule of Secured Convertible Notes Payable

Amounts outstanding under the Company’s convertible notes payable are as follows (amounts in 000’s except share amounts):

	March 31, 2024			December 31, 2023
Secured Convertible “Original” Notes Payable (A)	$	10,250		$	10,250
Secured Convertible “Option”” Notes Payable (B)		4,050			4,050
Secured Convertible “Option”” Notes Payable		4,050			4,050
Accrued interest		1,457			1,059

Accrued interest on excess debt borrowing		2,989			2,824
Capitalized financing costs		(554	)		(572	)
Total	$	18,192		$	17,611

Secured Convertible Notes

(A)

(B)

Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Option Activity

The following table summarizes stock option activity during the three months ended March 31, 2024:

Schedule of Stock Option Activity

	Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Terms (Years)		Aggregate Intrinsic Value
Outstanding at December 31, 2023		145,012		$	45.09		6.75	$	-
Granted		-		$	-
Exercised		-		$	-
Unvested forfeited		-		$	-
Vested forfeited		(3,143	)	$	45.05
Outstanding at March 31, 2024		141,869		$	44.03		6.50	$	-
Exercisable at March 31, 2024		111,583		$	51.09		6.07	$	-

Stock Warrants (Tables)

3 Months Ended

Mar. 31, 2024

Stock Warrants

Schedule of Warrant Activity

The Company’s warrant activity during the three months ended March 31, 2024 is as follows:

Schedule of Warrant Activity

	Shares		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Terms (Years)		Aggregate Intrinsic Value

Outstanding at December 31, 2023		549,292	$	8.77		2.84	$	-
Granted		-		-		-
Exercised		-		-		-
Forfeited		-		-		-
Outstanding at March 31, 2024		549,292	$	8.77		2.59	$	-
Exercisable at March 31, 2024		549,292	$	8.77		2.59	$	-

Transactions with California Custom Beverage, LLC, former related party (Tables)

3 Months Ended

Mar. 31, 2024

Schedule of Related Parties

At March 31, 2024 and 2023, accounts receivable due from and accounts payable due to CCB were as follows:

Schedule of Related Parties

	March 31, 2024			December 31, 2023
Accounts receivable, net of provision of $1,123 and $1,123 at March 31, 2024 and December 31, 2023, respectively		264			259
Accounts payable		(331	)		(259	)
Net (payable) receivable		(67	)		-

Schedule of Potentially Dilutive Securities (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	2,248,980	1,669,360
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	549,292	235,946
Equity Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	141,869	174,460
Convertible Notes Payable [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	1,557,066	1,257,491
Unvested Restricted Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total		710
Common Stock Equivalent of Series A Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	753	753

Summary of Significant Accounting Policies (Details Narrative) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)
Product Information [Line Items]
Cash	$ 314		$ 603
Additional cash received	$ 4,100
Shipping and handling costs	3.01	3.46
Advertising costs	$ 17	$ 55
Collection from customers	$ 1,217
Customer One [Member] \| Revenue Benchmark [Member] \| Product Concentration Risk [Member]
Product Information [Line Items]
Concentration risk, percentage	17.00%	18.00%
Customer One [Member] \| Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration risk, percentage	29.00%	24.00%
Customer Two [Member] \| Revenue Benchmark [Member] \| Product Concentration Risk [Member]
Product Information [Line Items]
Concentration risk, percentage	16.00%	12.00%
Customer Two [Member] \| Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration risk, percentage		15.00%
Customer Three [Member] \| Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration risk, percentage		11.00%
Vendor One [Member] \| Revenue Benchmark [Member] \| Product Concentration Risk [Member]
Product Information [Line Items]
Concentration risk, percentage	10.00%	11.00%
Vendor One [Member] \| Accounts Payable [Member] \| Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration risk, percentage	11.00%	10.00%
Vendor Two [Member] \| Accounts Payable [Member] \| Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration risk, percentage		10.00%

Schedule of Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw materials and packaging	$ 6,766	$ 6,445
Finished products	5,251	4,855
Total	$ 12,017	$ 11,300

Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Total cost	$ 1,577	$ 1,561
Accumulated depreciation and amortization	(1,136)	(1,068)
Net book value	441	493
Right of Use Assets Under Operating Leases [Member]
Property, Plant and Equipment [Line Items]
Total cost	724	724
Computer Hardware And Software [Member]
Property, Plant and Equipment [Line Items]
Total cost	400	400
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Total cost	352	352
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Total cost	$ 101	$ 85

Property and Equipment (Details Narrative) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Depreciation	$ 29	$ 47
Operating Lease, Right-of-Use Asset, Periodic Reduction	$ 39	$ 32

Summary of Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Brand names	$ 576	$ 576
Trademarks	55	53
Total	$ 631	$ 629

Schedule of Amount Outstanding Under Credit Facilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Line of Credit Facility [Line Items]
Total	$ 7,844	$ 9,758
Capitalized financing costs	(161)	(201)
Alterna Capital Solutions [Member]
Line of Credit Facility [Line Items]
Total	$ 8,005	$ 9,959

Line of Credit (Details Narrative) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
Line of Credit (Details Narrative) - USD ($) $ in Thousands	Mar. 31, 2022	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Line of Credit Facility [Line Items]
Amortization of Debt Discount (Premium)		$ 144	$ 281
Alterna Capital Solutions [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Term	3 years
Line of Credit Facility, Maximum Borrowing Capacity	$ 13,000	4,995
Line of Credit Facility, Maximum Amount Outstanding During Period	$ 400
Line of Credit Facility, Remaining Borrowing Capacity		0
Line of Credit Facility, Interest Rate Description	Borrowings based on receivables bears an interest of prime plus 4.75% but not less than 8.0% (13.25% at March 31, 2024 and 13.25% at December 31, 2023). Borrowings based on inventory bears an interest of prime plus 5.25% but not less than 8.5% (13.90% at March 31, 2024 and 13.90% at December 31, 2023). The additional over advance rider bears a rate of prime plus 12.75%, but not less than 16.00% (18.00% at March 31, 2024 and 18.00% at December 31, 2023). Additionally, the line of credit is subject to monthly monitoring fee of $1 with a minimum usage requirement on the credit facility.
Long-Term Line of Credit	$ 1,500
[custom:LineOfCreditMonitoringFee-0]	1
Direct Operating Costs	$ 483
[custom:AmortizationOfLineOfCreditPeriod]	3 years
Debt Instrument, Unamortized Discount		161		$ 201
Amortization of Debt Discount (Premium)		$ 40

Schedule of Secured Convertible Notes Payable (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Notes Payable A [Member]
Short-Term Debt [Line Items]
Secured Convertible “Option”” Notes Payable	$ 10,250	$ 10,250
Notes Payable B [Member]
Short-Term Debt [Line Items]
Secured Convertible “Option”” Notes Payable	4,050	4,050
Secured Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Accrued interest	1,457	1,059
Accrued interest on excess debt borrowing	2,989	2,824
Capitalized financing costs	(554)	(572)
Total	$ 18,192	$ 17,611

Schedule of Secured Convertible Notes Payable (Details) (Parenthetical) $ / shares in Units, $ in Thousands			1 Months Ended			3 Months Ended		4 Months Ended
	Feb. 12, 2024 USD ($) $ / shares	Aug. 11, 2022 USD ($)	Nov. 30, 2023 USD ($) Integer $ / shares	Aug. 31, 2022 USD ($)	May 31, 2022 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	May 31, 2023 USD ($)	Dec. 31, 2023 USD ($)	Jun. 30, 2023 USD ($)	Feb. 28, 2023 USD ($)
Short-Term Debt [Line Items]
Fee percentage		10.00%
Credit exceeds		$ 6,000				$ 8,285	$ 8,699
Debt Issuance Costs, Line of Credit Arrangements, Net										$ 7,500
Principal balance						10,250			$ 10,250
Convertiable notes payable						7,339			6,737
Whitebox Advisors, LLC [Member] \| Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Principal payment			$ 200
Debt conversion price \| $ / shares			$ 7.50
Payment for fees	$ 132					132
Share price \| $ / shares	$ 1.50
Whitebox Advisors, LLC [Member] \| Convertible Notes Payable [Member] \| Minimum [Member]
Short-Term Debt [Line Items]
Debt conversion percentage			1.25
Whitebox Advisors, LLC [Member] \| Convertible Notes Payable [Member] \| Maximum [Member]
Short-Term Debt [Line Items]
Debt conversion percentage			1.45
Whitebox Advisors, LLC [Member] \| Additional Option Notes [Member]
Short-Term Debt [Line Items]
Convertiable notes payable maturity date								Mar. 31, 2025
Principal balance						$ 4,050			$ 4,050
Debt conversion percentage			1.20
Convertiable notes payable								$ 4,050			$ 4,050
Debt conversion trading days \| Integer			5
Note Purchase Agreement [Member]
Short-Term Debt [Line Items]
Secured convertible promissory notes					$ 11,250
Debt Instrument, Interest Rate Terms					The Original Notes bear interest at 10% per annum (with 5% per annum payable in cash and 5% per annum payable in kind (“PIK”) by adding such PIK interest to the principal amount of the notes), are secured by substantially all of the Company’s assets (including all of its intellectual property) and are subject to a collateral sharing agreement with Alterna Capital (ACS), the Company’s existing secured lender.
Convertiable notes payable maturity date					Mar. 31, 2025
Principal payment				$ 200
Weighted average interest				90.00%

Secured Convertible Notes Payable (Details Narrative) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Feb. 12, 2024	Dec. 31, 2023
Short-Term Debt [Line Items]
Interest on convertible notes	$ 1,023	$ 1,779
Amortization of debt discount	144	$ 281
Whitebox Advisors, LLC [Member] \| Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Accrued interest	4,446			$ 3,883
Interest on convertible notes	563
Interest expenses	398
Excess of asset base loan fees	165
Unamortized debt discount amount	554			$ 572
Incurred costs for aforementioned waivers	86
Amortization of debt discount	$ 104
Limited Waiver, Deferral, and Amendment and Restatement Agreement [Member]
Short-Term Debt [Line Items]
Future minimum equity financing			$ 3,000
Conversion of SAFE investments into equity			4,100
Accrued interest			$ 100

Leases Liabilities (Details Narrative) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Leases [Abstract]
Lease cost	$ 39	$ 32
Operating leases liability	155		$ 207
Payments of operating lease liability	$ 52
Weighted average remaining lease term for operating lease	9 months
Weighted average discount rate for operating lease	12.60%

Simple Agreements for Future Equity (“SAFE”) Investments (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from Related Party Debt	$ 264	$ 259
Simple Agreements For Future Equity Investments [Member] \| Stockholders [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from Related Party Debt	$ 4,100
Share price	$ 1.50

Schedule of Stock Option Activity (Details) - USD ($)	3 Months Ended	12 Months Ended
Schedule of Stock Option Activity (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Shares Outstanding, Beginning balance	145,012
Weighted-Average Exercise Price, Outstanding	$ 45.09
Weighted-Average Remaining Contractual Terms (Years), Outstanding	6 years 6 months	6 years 9 months
Aggregate Intrinsic Value, Shares Outstanding
Shares, Granted
Weighted-Average Exercise Price, Granted
Shares, Exercised
Weighted-Average Exercise Price, Exercised
Shares, Unvested forfeited
Weighted-Average Exercise Price, Unvested forfeited
Shares, Vested forfeited	(3,143)
Weighted-Average Exercise Price, Vested forfeited	$ 45.05
Shares Outstanding, Ending balance	141,869	145,012
Weighted-Average Exercise Price, Outstanding	$ 44.03	$ 45.09
Aggregate Intrinsic Value, Shares Outstanding
Shares, Exercisable	111,583
Weighted-Average Exercise Price, Exercisable	$ 51.09
Weighted-Average Remaining Contractual Terms (Years), Exercisable	6 years 25 days
Aggregate Intrinsic Value

Stock-Based Compensation (Details Narrative) - Share-Based Payment Arrangement, Option [Member] - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Fair value of vested stock option	$ 129	$ 229
Aggregate value of unvested compensation	$ 314
Stock price	$ 1.63

Schedule of Warrant Activity (Details) - Warrant [Member] - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding, Beginning balance	549,292
Weighted average exercise price, outstanding	$ 8.77
Weighted average remaining contractual terms (years), outstanding	2 years 7 months 2 days	2 years 10 months 2 days
Aggregate intrinsic value shares outstanding beginning
Shares, granted
Weighted average exercise price, granted
Shares, exercised
Weighted average exercise price, exercised
Shares, forfeited
Weighted average exercise price, forfeited
Shares outstanding, Ending balance	549,292	549,292
Weighted average exercise price, outstanding ending balance	$ 8.77	$ 8.77
Aggregate intrinsic value shares outstanding
Shares exercisable	549,292
Weighted average exercise price, exercisable	$ 8.77
Weighted average remaining contractual terms (years), exercisable	2 years 7 months 2 days
Aggregate intrinsic value shares exercisable

Stock Warrants (Details Narrative)	Mar. 31, 2024 $ / shares
Securities Purchase Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Warrants exerice price	$ 1.63

Schedule of Related Parties (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Related Party Transactions [Abstract]
Accounts receivable, net of provision of $1,123 and $1,123 at March 31, 2024 and December 31, 2023, respectively	$ 264	$ 259
Accounts payable	(331)	(259)
Net (payable) receivable	$ (67)

Schedule of Related Parties (Details) (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Related Party [Member]
Related Party Transaction [Line Items]
Net of provision	$ 1,123	$ 1,123

Transactions with California Custom Beverage, LLC, former related party (Details Narrative) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Dec. 31, 2018
California Custom Beverage, LLC [Member]
Related Party Transaction [Line Items]
Due to related party	$ 452	$ 452
Christopher J. Reed [Member] \| California Custom Beverage, LLC [Member]
Related Party Transaction [Line Items]
Royalty percentage			5.00%

Commitments and Contingencies (Details Narrative) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Dec. 31, 2018
Chris Reed [Member] \| California Custom Beverage, LLC [Member]
Loss Contingencies [Line Items]
Deposit of security with lessor	$ 800		$ 1,200
Escrow deposits	$ 12
Chris Reed [Member] \| California Custom Beverage, LLC [Member] \| Common Stock [Member]
Loss Contingencies [Line Items]
Number of common stock value placed	7,260
Maximum [Member]
Loss Contingencies [Line Items]
Fees		$ 1,200

Subsequent Events (Details Narrative) - Secured Convertible Notes Payable [Member] - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Jul. 01, 2024
Subsequent Event [Line Items]
Minimum of conversion amount	$ 3,000
Conversion amount	$ 4,100
Subsequent Event [Member]
Subsequent Event [Line Items]
Interest payable		$ 40